Hints and tips:
Related Special Reports
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...Instead, Isomorphic chose to sign deals with just two pharmaceutical companies....
Millions of Paxlovid pills have gone unused as tight controls restrict access
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
Investor worries about the impact of weight loss drugs on food companies are overdone
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
...Together with investors including hedge fund manager Steve Cohen and Atlanta Falcons NFL franchise owner Arthur Blank, Henry and Fenway are paying up to $3bn for a minority stake....
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
Using AI should speed up detection of diseases caused by genetic variants but it does not guarantee success
Private equity group’s bid for researcher comes as the biomedical market is slowing down post-Covid
First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants
...But until recently, many large pharmaceutical companies were reluctant to invest heavily in finding treatments after decades of failure....
...The virtue of putting private collections on public display is inculcated in Switzerland’s merchant class, the heirs to textile and pharmaceutical fortunes....
Shionogi chief warns companies are deserting the field to focus on more lucrative areas
...In the second quarter of 2023 the FTSE All-Share pharmaceutical and biotechnology price return index closed 13 per cent higher than the FTSE All Share price return index....
Japan’s Eisai says it will not finalise Leqembi spending plans until government clarifies financial support
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
...Pharmaceutical companies including AstraZeneca and Johnson and Johnson already work with the UK Biobank to access genomic data....
...Developed by Jaxa in partnership with Mitsubishi Heavy Industries, the H3 launched at an ambitious cost of ¥5bn ($37mn), half that of its predecessor and the $67mn needed for a Falcon 9 launch....
...It also generated excitement across the pharmaceutical industry, which is enticed by the prospect of selling medicines to the more than 50mn people worldwide who suffer from the disease....
...more than 10 per cent over the past five trading days while Shanghai Fosun Pharmaceutical added 7 per cent....
Unexpected finding suggests popular sweetener could treat autoimmune conditions such as arthritis and diabetes
...That’d be bad news for Hikma Pharmaceuticals (27.2 per cent). What about board chairs and their deputies?...
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...Other executives at Isomorphic include Miles Congreve, chief scientific officer, who previously worked at Astex Pharmaceuticals and GSK....
International Edition